Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic
- PMID: 33346795
- PMCID: PMC7754073
- DOI: 10.1001/jamainternmed.2020.7497
Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic
Abstract
This cohort study examines changes in the number of buprenorphine prescriptions fill by individuals with opioid use disorder before and during the coronavirus disease 2019 pandemic.
Conflict of interest statement
Figures
Comment in
-
Buprenorphine Opioid Treatment During the COVID-19 Pandemic.JAMA Intern Med. 2021 Aug 1;181(8):1135. doi: 10.1001/jamainternmed.2021.0777. JAMA Intern Med. 2021. PMID: 33843962 No abstract available.
References
-
- Ahmad FB, Rossen LM SP. Provisional drug overdose death counts. National Center for Health Statistics. Reviewed September 16, 2020. Accessed October 10, 2020. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
-
- American Society of Addiction Medicine . Access to buprenorphine in office-based settings: ASAM COVID-19 Task Force Recommendations. Published 2020. Accessed October 10, 2020. https://www.asam.org/Quality-Science/covid-19-coronavirus/access-to-bupr...
-
- Centers for Disease Control and Prevention . Data resources: analyzing opioid prescription data and oral morphine milligram equivalents (MME), 2018. version. Reviewed October 9, 2020. Accessed January 8, 2020. https://www.cdc.gov/drugoverdose/resources/data.html
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
